Description
GenJet™ DNA In Vitro Tranfection Reagent for BHK-21 cell is pre-optimized for transfecting BHK-21 cells. BHK-21 cells is one of the most commonly used cells for vaccine production. When used for this application, usually a cell strain adapted to grow in suspension is used.
Refer to the following optimal transfection conditions for maximal transfection efficiency on BHK-21 cells. GenJet™ reagent, 1.0 ml, is sufficient for 300 to 600 transfections in 24 well plates or 150 to 300 transfections in 6 well plates.
Summary of Optimal Transfection Conditions:
Confluence on the day of transfection
|
80% |
| Cell culture conditions |
DMEM with 4.5 g/L glucose, 10% FBS
|
| GenJet™ (µl) : DNA (µg) Ratio |
3:1 |
Diluent for DNA and Transfection Reagent
|
Serum-free DMEM with 4.5 g/L glucose
|
| Incubation Time to Form GenJet™/DNA Complex |
15 minutes at RT |
| Presence of Serum/Antibiotics during Transfection |
Yes |
| Change Medium After Transfection |
Yes, 5 Hours After Transfection |
| Maximal Efficiency |
48 hours |
Transfection Results:
Reporter Gene
|
EGFP |
Plasmid
|
pEGFP-N3 (CMV promoter)
|
| Efficiency (GFP %) |
85% |
Storage Condition
Store at 4 °C. If stored properly, the product is stable for 12 months or longer
Data Sheet 
